First Page | Document Content | |
---|---|---|
Date: 2016-07-11 17:00:34Medicine Clinical medicine Inborn errors of purine-pyrimidine metabolism Uric acid Chemistry Pegloticase Gout Hyperuricemia Savient pharmaceuticals Urate oxidase Allopurinol Allantoin | Microsoft Word - puricase-Phase I-ivpress release.docAdd to Reading ListSource URL: www.mvpharm.comDownload Document from Source WebsiteFile Size: 28,79 KBShare Document on Facebook |
Microsoft Word - Savient Phase 3 Dosing press releasedocDocID: 1ri7E - View Document | |
Microsoft Word - Savient press release re ACRdocDocID: 1reUR - View Document | |
Microsoft Word - Savient press release Puricase SPAdocDocID: 1qW9f - View Document | |
Microsoft Word - puricase-Phase I-ivpress release.docDocID: 1qOjy - View Document | |
Microsoft Word - Savient Reports Positive Top-Line ResultsdocDocID: 1qCIQ - View Document |